12 February 2025
12 February 2025
Merck acquisition target SpringWorks will go toe-to-toe with AstraZeneca in the US neurofibromatosis market.
Travere’s stock price climbed by 14% following the announcement that it will seek an FDA label expansion for Filspari.
WHO aims to reach 120,000 children with cancer who do not have access to safe and effective treatments.
Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.
Sponsors need to try and solve the issue of inadequate enrolment by having better site relationships.
The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive approach to AI.
The upfront net proceeds from this private placement will be allocated for general corporate purposes.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
